Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Chiral arylketones in the treatment of neutrophil-dependent inflammatory diseases

Chiral arylketones in the treatment of neutrophil-dependent inflammatory diseases

US Patent 9328057 · Granted May 3, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Co-crystal of ketoprofen, lysine and gabapentin, pharmaceutical compositions and2025
IL-17A binding peptides and medical uses thereof2025
IL-8 inhibitors for use in the treatment of chemotherapy-induced peripheral neur2025
Composition containing branched-chain amino acids2025
IL-8 inihibitors for use in the treatment of some urological disorders2024
IL-8 inihibitors for use in the treatment of some urological disorders2024
IL-8 inhibitors for use in the treatment and/or prevention of bacterial secondar2024
C5aR inhibitors for use in the treatment of chemotherapy-induced iatrogenic pain2024
Prevention and treatment of diabetic nephropathy2024
Prevention and treatment of diabetic nephropathy2022
IL-17A binding peptides and medical uses thereof2022
Use of 1,25-dihydroxyvitamin D values in ratio with PTH as a prognostic biomarke2021